Trial · NCT01473589
Results by group38
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 38
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture | Teriparatide | 87 | 90% Confidence Interval 77 to 93 | percentage of participants | |
| Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture | Placebo | 86 | 90% Confidence Interval 76 to 92 | percentage of participants | |
| Percentage of Participants With Radiographic Evidence of Healing | Teriparatide | 78.3 | percentage of participants | ||
| Percentage of Participants With Radiographic Evidence of Healing | Placebo | 78.7 | percentage of participants | ||
| Percentage of Participants With Pain Control During Ambulation | Teriparatide | 91.5 | percentage of participants | ||
| Percentage of Participants With Pain Control During Ambulation | Placebo | 89.8 | percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During 24 Hours Prior to Visit | Teriparatide | 88.0 | percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During 24 Hours Prior to Visit | Placebo | 82.4 | percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During Weight Bearing | Teriparatide | 89.4 | percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During Weight Bearing | Placebo | 88.0 | percentage of participants | ||
| Percentage of Participants With Functional Evidence of Healing | Teriparatide | 85.4 | percentage of participants | ||
| Percentage of Participants With Functional Evidence of Healing | Placebo | 74.0 | percentage of participants | ||
| Percentage of Participants Able to Ambulate | Teriparatide | 97.9 | percentage of participants | ||
| Percentage of Participants Able to Ambulate | Placebo | 98 | percentage of participants | ||
| Percentage of Participants Who Regain Their Prefracture Ambulatory Status | Teriparatide | 73.2 | percentage of participants | ||
| Percentage of Participants Who Regain Their Prefracture Ambulatory Status | Placebo | 56.9 | percentage of participants | ||
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Teriparatide | During ambulation (n = 45, 46) | 0.2 | Standard Error 0.37 | units on a scale |
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Placebo | During ambulation (n = 45, 46) | 0.2 | Standard Error 0.36 | units on a scale |
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Teriparatide | During 24 hours preceding visit (n = 47, 50) | -0.3 | Standard Error 0.45 | units on a scale |
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Placebo | During 24 hours preceding visit (n = 47, 50) | -0.8 | Standard Error 0.42 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01473589/results